semaglutide ileus class action in west virginia glp-1 gastric stasis law office kentucky legal team lawyer Wegovy Lawsuit Lawyer kentucky intestinal obstruction – glp-1 gastroparesis in – glp-1 bowel obstruction attorney in

This injectable form was first approved by the FDA in December 2017 for the treatment of type 2 diabetes, reducing the risk of major cardiovascular events in patients with type 2 diabetes and cardiovascular disease, and reducing the risk of kidney disease progression and cardiovascular death in patients with type 2 diabetes and chronic kidney disease

(April 2016)

Currently, there is limited insurance coverage for these medications There are current supply shortages To maintain results you need to take the medication

Standard dose ranges from 100-300mcg per injection

The competitive landscape intensified in 2023 when Eli Lilly entered the market with a differentiated clinical profile